Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osnaghi

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Medical Virology|June 28, 2022
Prevalence of anti-parvovirus B19 IgG and IgM and parvovirus B19 viremia in pregnant women in an urban area of Northern ItalyMassimo De Paschale, Claudia Pavia, Teresa Cerulli, et al.
The Journal of Pediatrics|September 24, 2013
Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectivesLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
European Journal of Pediatrics|September 26, 2024
Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitisDaniele Giovanni Ghiglioni, Gaia Bruschi, Elena Chiappini, et al.
BMC Pediatrics|November 20, 2010
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491Luca Filippi, Giacomo Cavallaro, Patrizio Fiorini, et al.
Pediatric Research|November 5, 2016
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trialLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
BMC Pediatrics|July 16, 2017
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trialLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Pediatrics|May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB StudyLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Medical Virology|June 28, 2022
Prevalence of anti-parvovirus B19 IgG and IgM and parvovirus B19 viremia in pregnant women in an urban area of Northern ItalyMassimo De Paschale, Claudia Pavia, Teresa Cerulli, et al.
The Journal of Pediatrics|September 24, 2013
Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectivesLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
European Journal of Pediatrics|September 26, 2024
Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitisDaniele Giovanni Ghiglioni, Gaia Bruschi, Elena Chiappini, et al.
BMC Pediatrics|November 20, 2010
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491Luca Filippi, Giacomo Cavallaro, Patrizio Fiorini, et al.
Pediatric Research|November 5, 2016
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trialLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.
BMC Pediatrics|July 16, 2017
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trialLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Frontiers in Pediatrics|May 29, 2019
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB StudyLuca Filippi, Giacomo Cavallaro, Elettra Berti, et al.
Pageof 4